Cultural

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation

01-03

Wonderful Indonesia Co-Branding: A Kaleidoscope of Achievements in 2024

JAKARTA,Indonesia,Dec. 30,2024-- The Ministry of Tourism and Creative Economy has highlighted key achievements from its Wonderful Indonesia Co-Branding partnership in 2024. The program has effectively

01-03

Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent

TOKYO,Dec. 25,2024-- Kaneka has successfully defended its patent for stabilizing Ubiquinol.On December 20,2024,Kaneka Corporation won its lawsuit against Designs for Health,Inc. and American River Nu

01-03 Kaneka Corporation

Chancay Port serves as bridge between South America and Asia

BEIJING,Dec. 26,2024-- A report from People\'s Daily: Gonzalo Rios is the deputy general manager of COSCO Shipping Ports Chancay Peru S.A.

01-03 People's Daily

Lichen China Limited Announces $2.8 Million Registered Direct Offering

XIAMEN,China,Dec. 27,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it

01-03 Lichen China Limited

HSG Laser Opens New Manufacturing Facility in Jinan, China and Unveils 120kW Laser Cutter

CHICAGO,Dec. 26,2024-- HSG Laser,a global leader in metal shaping equipment and solutions,proudly announces the grand opening of its newest manufacturing facility in Jinan,China—a key milestone in it

01-03 HSG Laser

Thinkfree showcases AI-Driven future workplace at CES 2025

LAS VEGAS and SEOUL,South Korea,Dec. 27,2024--Thinkfree,a global software company in productivity tools and AI technology,will participate in CES 2025,taking place in Las Vegas from January 7 to Janu

01-03 THINKFREE

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation

01-03 Alphamab Oncology

ARTERY 2024: Redefining MCU Innovation for a Smarter Future

TAIPEI,Dec. 30,2024-- As the calendar turns,ARTERY Technology extends warm New Year greetings! In 2024,leveraging professional expertise and technological breakthroughs,we made steady progress in a ra

01-03 Artery Technology

Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award

NANTONG and SUZHOU,China,Dec. 31,2024-- Ractigen Therapeutics proudly announces that its Founder and CEO,Dr. Long-Cheng Li,has been honored with the 2024 Life Science Ice Breaking Award. This award,es

01-03 Ractigen Therapeutics